Replies to post #537317 on NorthWest Biotherapeutics Inc (NWBO)

[Poor Man -]

The bottom line is that any OTC stock will be limited in terms of growth potential and retaining value — there are just too few buyers and no meaningful number of institutional investors. Frankly, it’s mostly a trader oriented exchange.

I’ve said it for years, that NWBO will find it difficult to get over the $1 billion market cap threshold and remain there. And that’s exactly what we’ve been seeing. The last two days have been profit taking, nothing to do with AF.

The only remedy is to up list — the faster, the better. Or I’ll be back on the bench, likely in a cast this time.

I’m dying if I’m lying.